ANI Pharmaceuticals, Inc. (ANIP)
71.47
+0.41
(+0.58%)
USD |
NASDAQ |
Nov 13, 16:00
71.47
0.00 (0.00%)
After-Hours: 19:59
ANI Pharmaceuticals Price : 71.47 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 71.56 | 71.82 | 70.00 | 71.06 | 361301.0 |
| Nov 11, 2026 | 70.87 | 72.24 | 70.38 | 71.09 | 1.012M |
| Nov 10, 2026 | 67.53 | 71.36 | 67.53 | 71.25 | 1.189M |
| Nov 09, 2026 | 67.70 | 68.52 | 67.38 | 67.79 | 483964.0 |
| Nov 06, 2026 | 69.05 | 70.94 | 67.14 | 67.41 | 578180.0 |
| Nov 05, 2026 | 73.00 | 76.00 | 68.78 | 69.62 | 1.296M |
| Nov 04, 2026 | 73.22 | 74.00 | 71.36 | 71.65 | 304431.0 |
| Nov 03, 2026 | 70.99 | 72.37 | 70.88 | 72.28 | 371252.0 |
| Nov 02, 2026 | 72.21 | 72.92 | 70.66 | 70.67 | 514718.0 |
| Oct 30, 2026 | 73.27 | 73.54 | 71.90 | 72.00 | 286897.0 |
| Oct 29, 2026 | 72.68 | 73.62 | 72.05 | 73.16 | 262411.0 |
| Oct 28, 2026 | 70.78 | 72.76 | 70.31 | 71.71 | 335905.0 |
| Oct 27, 2026 | 72.18 | 72.41 | 70.74 | 71.17 | 285234.0 |
| Oct 26, 2026 | 72.74 | 73.84 | 72.02 | 72.60 | 229291.0 |
| Oct 23, 2026 | 73.30 | 73.42 | 72.05 | 72.61 | 318598.0 |
| Oct 22, 2026 | 72.50 | 74.15 | 71.85 | 73.75 | 454415.0 |
| Oct 21, 2026 | 72.44 | 73.51 | 71.80 | 72.24 | 345033.0 |
| Oct 20, 2026 | 73.31 | 74.00 | 72.42 | 72.67 | 264960.0 |
| Oct 19, 2026 | 72.41 | 73.21 | 72.32 | 72.56 | 253639.0 |
| Oct 16, 2026 | 72.65 | 73.08 | 71.50 | 72.29 | 333932.0 |
| Oct 15, 2026 | 71.08 | 73.20 | 71.02 | 72.28 | 240988.0 |
| Oct 14, 2026 | 70.54 | 72.31 | 69.90 | 70.16 | 269202.0 |
| Oct 13, 2026 | 73.59 | 73.59 | 70.44 | 70.84 | 331803.0 |
| Oct 12, 2026 | 74.00 | 74.28 | 72.80 | 73.59 | 318479.0 |
| Oct 09, 2026 | 71.87 | 74.43 | 71.25 | 73.89 | 540837.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1444.57 |
| Supernus Pharmaceuticals, Inc. | 29.70 |
| Ocular Therapeutix, Inc. | 6.205 |
| Corcept Therapeutics, Inc. | 72.96 |
| Veru, Inc. | 2.12 |
Price Related Metrics
| PE Ratio | 14.27 |
| PS Ratio | 1.491 |
| PEG Ratio | 0.0689 |
| Price to Book Value | 2.569 |
| Price to Free Cash Flow | 7.767 |
| Earnings Yield | 7.01% |
| Market Cap | 1.637B |
| PEGY Ratio | 0.0689 |
| Operating PE Ratio | 9.735 |
| Normalized PE Ratio | 15.66 |